Skip to content
All news
Analysis

Invest $5,000 in Johnson & Johnson for Quarterly Passive Income

Johnson & Johnson (JNJ) offers investors a way to earn regular passive income through quarterly dividends. With a $5,000 investment, the annual yield is around 3.2%, making it an attractive option for income-focused investors.

May 5, 2026
2 min read
Source: 24/7 Wall St.
Share:

Key Numbers

dividend yield
3.2%
investment amount
5,000 USD
quarterly dividend
1.19 USD per share

Johnson & Johnson (JNJ) is one of the market's premier dividend stocks, providing consistent income through quarterly payouts. With a dividend yield of approximately 3.2%, a $5,000 investment can generate roughly $160 in annual dividends, or $40 per quarter.

Why Johnson & Johnson?

The company has a long history of dividend increases spanning over 50 years, earning it a spot among the Dividend Aristocrats. Its diversified healthcare business—pharmaceuticals, medical devices, and consumer products—provides stable cash flows.

How to Generate Passive Income?

At a share price of around $150, $5,000 buys about 33 shares. JNJ currently pays $1.19 per share quarterly, totaling $39.27 per quarter ($157 annually). Reinvesting these dividends can compound future income.

Risks and Considerations

While JNJ is a strong company, dividends are not guaranteed and can be affected by market conditions or company performance. The healthcare sector faces regulatory and competitive challenges. However, JNJ's long dividend history lends it high credibility.

What It Means for Investors?

For those seeking reliable passive income, JNJ offers a balanced choice between yield and safety. It can be a core holding in an income-focused portfolio, especially for investors nearing retirement.

Frequently Asked Questions

The current quarterly dividend is $1.19 per share, equating to $4.76 annually.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.